Glenmark Pharmaceuticals Ltd.
•₹ 2,317.9-0.64%
2026-08-21
PROS
- Company is almost debt free
- Latest quarter profit grew 122.8% YoY, showing strong momentum
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
CONS
- Company is loss-making at the operating / net level
- Recent results are weak - TTM profit is down 74.8% versus prior year
- Receivables are growing faster than sales - a possible quality concern
- Interest coverage is weak at -2.4x - earnings barely cover interest
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.10x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | GLENMARK | 2325.00 | 36.50 | 65617.24 | 0.11 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,098 | 2,170 | 1,304 | 2,077 | 2,297 | 2,595 | 2,209 | 1,910 | 2,179 | 1,220 | 2,328 | 2,208 | 2,435 | |
| 1,659 | 1,790 | 1,549 | 1,651 | 1,698 | 1,857 | 1,757 | 1,669 | 1,667 | 1,717 | 1,864 | 2,115 | 1,907 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 49 | 74 | 259 | 786 | 56 | 83 | 129 | 88 | 69 | 286 | 109 | 308 | 115 |
| Interest | 62 | 58 | 74 | 83 | 15 | 12 | 8 | 13 | 15 | 23 | 22 | 18 | 23 |
| Depreciation | 49 | 50 | 51 | 52 | 53 | 55 | 55 | 56 | 58 | 59 | 59 | 60 | 62 |
| 392 | 389 | -76 | 6,295 | 618 | 795 | 559 | 181 | 401 | -906 | 347 | -107 | 866 | |
| Tax % | 30.71% | 22.35% | 72.97% | 26.71% | 26.62% | 25.16% | 26.04% | 18.44% | 17.68% | 18.45% | 18.60% | 31.19% | 15.06% |
| Net Profit | 272 | 302 | -20 | 4,614 | 454 | 595 | 414 | 148 | 330 | -739 | 282 | -74 | 736 |
| 10 | 11 | -1 | 164 | 16 | 21 | 15 | 5 | 12 | -26 | 10 | -3 | 3 | |
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 2,098
- 1,659
- Operating Profit
- —
- OPM %
- —
- Other Income
- 49
- Interest
- 62
- Depreciation
- 49
- 392
- Tax %
- 30.71%
- Net Profit
- 272
- 10
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 2,170
- 1,790
- Operating Profit
- —
- OPM %
- —
- Other Income
- 74
- Interest
- 58
- Depreciation
- 50
- 389
- Tax %
- 22.35%
- Net Profit
- 302
- 11
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 1,304
- 1,549
- Operating Profit
- —
- OPM %
- —
- Other Income
- 259
- Interest
- 74
- Depreciation
- 51
- -76
- Tax %
- 72.97%
- Net Profit
- -20
- -1
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 2,077
- 1,651
- Operating Profit
- —
- OPM %
- —
- Other Income
- 786
- Interest
- 83
- Depreciation
- 52
- 6,295
- Tax %
- 26.71%
- Net Profit
- 4,614
- 164
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 2,297
- 1,698
- Operating Profit
- —
- OPM %
- —
- Other Income
- 56
- Interest
- 15
- Depreciation
- 53
- 618
- Tax %
- 26.62%
- Net Profit
- 454
- 16
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 2,595
- 1,857
- Operating Profit
- —
- OPM %
- —
- Other Income
- 83
- Interest
- 12
- Depreciation
- 55
- 795
- Tax %
- 25.16%
- Net Profit
- 595
- 21
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 2,209
- 1,757
- Operating Profit
- —
- OPM %
- —
- Other Income
- 129
- Interest
- 8
- Depreciation
- 55
- 559
- Tax %
- 26.04%
- Net Profit
- 414
- 15
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 1,910
- 1,669
- Operating Profit
- —
- OPM %
- —
- Other Income
- 88
- Interest
- 13
- Depreciation
- 56
- 181
- Tax %
- 18.44%
- Net Profit
- 148
- 5
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 2,179
- 1,667
- Operating Profit
- —
- OPM %
- —
- Other Income
- 69
- Interest
- 15
- Depreciation
- 58
- 401
- Tax %
- 17.68%
- Net Profit
- 330
- 12
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 1,220
- 1,717
- Operating Profit
- —
- OPM %
- —
- Other Income
- 286
- Interest
- 23
- Depreciation
- 59
- -906
- Tax %
- 18.45%
- Net Profit
- -739
- -26
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 2,328
- 1,864
- Operating Profit
- —
- OPM %
- —
- Other Income
- 109
- Interest
- 22
- Depreciation
- 59
- 347
- Tax %
- 18.60%
- Net Profit
- 282
- 10
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 2,208
- 2,115
- Operating Profit
- —
- OPM %
- —
- Other Income
- 308
- Interest
- 18
- Depreciation
- 60
- -107
- Tax %
- 31.19%
- Net Profit
- -74
- -3
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 2,435
- 1,907
- Operating Profit
- —
- OPM %
- —
- Other Income
- 115
- Interest
- 23
- Depreciation
- 62
- 866
- Tax %
- 15.06%
- Net Profit
- 736
- 3
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 28
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8,096 | 6,432 | 6,305 | 6,713 | 7,568 | 8,142 | 8,221 | 7,891 | 9,226 | 8,440 | 8,190 | |
| 5,197 | 5,107 | 4,977 | 5,408 | 5,678 | 6,453 | 6,748 | 6,649 | 6,982 | 7,363 | 7,603 | |
| Operating Profit | 3,047 | 1,506 | 1,803 | 1,911 | 2,287 | 2,303 | 2,459 | 2,410 | 2,601 | 1,849 | — |
| OPM % | 38 | 23 | 29 | 28 | 30 | 28 | 30 | 31 | 28 | 22 | — |
| Other Income | 148 | 180 | 476 | 607 | 396 | 615 | 986 | 1,168 | 356 | 772 | 818 |
| Interest | 153 | 191 | 224 | 256 | 266 | 236 | 207 | 277 | 49 | 79 | 87 |
| Depreciation | 105 | 96 | 106 | 139 | 151 | 160 | 184 | 202 | 219 | 236 | 241 |
| 2,553 | 1,219 | 1,818 | 1,535 | 1,944 | 2,337 | 1,572 | 7,001 | 2,154 | -266 | 199 | |
| Tax % | 16 | 17 | 18 | 12 | 15 | 15 | 23 | 26 | 25 | 25 | -3 |
| Net Profit | 2,141 | 1,014 | 1,488 | 1,355 | 1,649 | 1,998 | 1,209 | 5,167 | 1,610 | -201 | 205 |
| EPS | 76 | 36 | 57 | 48 | 58 | 71 | 43 | 183 | 57 | -7 | — |
| Dividend Payout % | 3 | 6 | 4 | 5 | 4 | 4 | 6 | 1 | 4 | -35 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 76 | 36 | 53 | 48 | 58 | 71 | 43 | 183 | 57 | -7 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 76 | 36 | 53 | 48 | 58 | 71 | 43 | 183 | 57 | -7 | — |
Mar 2017
- 8,096
- 5,197
- Operating Profit
- 3,047
- OPM %
- 38
- Other Income
- 148
- Interest
- 153
- Depreciation
- 105
- 2,553
- Tax %
- 16
- Net Profit
- 2,141
- EPS
- 76
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 76
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 76
Mar 2018
- 6,432
- 5,107
- Operating Profit
- 1,506
- OPM %
- 23
- Other Income
- 180
- Interest
- 191
- Depreciation
- 96
- 1,219
- Tax %
- 17
- Net Profit
- 1,014
- EPS
- 36
- Dividend Payout %
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 36
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 36
Mar 2019
- 6,305
- 4,977
- Operating Profit
- 1,803
- OPM %
- 29
- Other Income
- 476
- Interest
- 224
- Depreciation
- 106
- 1,818
- Tax %
- 18
- Net Profit
- 1,488
- EPS
- 57
- Dividend Payout %
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 53
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 53
Mar 2020
- 6,713
- 5,408
- Operating Profit
- 1,911
- OPM %
- 28
- Other Income
- 607
- Interest
- 256
- Depreciation
- 139
- 1,535
- Tax %
- 12
- Net Profit
- 1,355
- EPS
- 48
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 48
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 48
Mar 2021
- 7,568
- 5,678
- Operating Profit
- 2,287
- OPM %
- 30
- Other Income
- 396
- Interest
- 266
- Depreciation
- 151
- 1,944
- Tax %
- 15
- Net Profit
- 1,649
- EPS
- 58
- Dividend Payout %
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 58
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 58
Mar 2022
- 8,142
- 6,453
- Operating Profit
- 2,303
- OPM %
- 28
- Other Income
- 615
- Interest
- 236
- Depreciation
- 160
- 2,337
- Tax %
- 15
- Net Profit
- 1,998
- EPS
- 71
- Dividend Payout %
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 71
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 71
Mar 2023
- 8,221
- 6,748
- Operating Profit
- 2,459
- OPM %
- 30
- Other Income
- 986
- Interest
- 207
- Depreciation
- 184
- 1,572
- Tax %
- 23
- Net Profit
- 1,209
- EPS
- 43
- Dividend Payout %
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 43
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 43
Mar 2024
- 7,891
- 6,649
- Operating Profit
- 2,410
- OPM %
- 31
- Other Income
- 1,168
- Interest
- 277
- Depreciation
- 202
- 7,001
- Tax %
- 26
- Net Profit
- 5,167
- EPS
- 183
- Dividend Payout %
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 183
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 183
Mar 2025
- 9,226
- 6,982
- Operating Profit
- 2,601
- OPM %
- 28
- Other Income
- 356
- Interest
- 49
- Depreciation
- 219
- 2,154
- Tax %
- 25
- Net Profit
- 1,610
- EPS
- 57
- Dividend Payout %
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 57
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 57
Mar 2026
- 8,440
- 7,363
- Operating Profit
- 1,849
- OPM %
- 22
- Other Income
- 772
- Interest
- 79
- Depreciation
- 236
- -266
- Tax %
- 25
- Net Profit
- -201
- EPS
- -7
- Dividend Payout %
- -35
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
TTM
- 8,190
- 7,603
- Operating Profit
- —
- OPM %
- —
- Other Income
- 818
- Interest
- 87
- Depreciation
- 241
- 199
- Tax %
- -3
- Net Profit
- 205
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 3%
- 5 Years:
- 2%
- 3 Years:
- 1%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 11%
- 5 Years:
- 34%
- 3 Years:
- 45%
- 1 Year:
- 19%
RETURN ON EQUITY
- 10 Years:
- 12%
- 5 Years:
- 10%
- 3 Years:
- 10%
- Last Year:
- -1%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 | 28 |
| 9,407 | 10,353 | 11,903 | 13,184 | 14,766 | 16,708 | 17,847 | 22,940 | 24,473 | 24,117 | |
| 187 | 295 | 303 | 443 | 513 | 370 | 350 | 500 | 699 | 0 | |
| Trade Payables | 1,467 | 1,555 | 1,668 | 1,585 | 1,623 | 1,939 | 2,093 | 2,700 | 2,182 | 2,746 |
| 4,235 | 2,373 | 2,528 | 4,498 | 6,077 | 6,575 | 6,607 | 5,241 | 5,388 | 7,325 | |
| Total Liabilities | 15,324 | 14,604 | 16,431 | 19,738 | 23,007 | 25,619 | 26,925 | 31,410 | 32,770 | 34,216 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 1,596 | 1,699 | 1,413 | 1,612 | 1,722 | 1,752 | 1,746 | 1,756 | 1,979 | 2,028 | |
| Capital Work in Progress | 235 | 354 | 209 | 152 | 93 | 101 | 159 | 175 | 121 | 67 |
| 1,867 | 3,213 | 3,269 | 4,714 | 6,990 | 8,559 | 10,333 | 12,965 | 15,195 | 15,202 | |
| 1,145 | 1,111 | 911 | 838 | 762 | 952 | 1,090 | 1,143 | 1,369 | 1,288 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,484 | 2,550 | 3,306 | |
| Cash & Bank | 252 | 177 | 256 | 88 | 16 | 30 | 94 | 129 | 133 | 293 |
| 10,229 | 8,050 | 10,371 | 12,334 | 13,423 | 14,225 | 13,503 | 12,757 | 11,423 | 12,032 | |
| Total Assets | 15,324 | 14,604 | 16,431 | 19,738 | 23,007 | 25,619 | 26,925 | 31,410 | 32,770 | 34,216 |
| Total Debt | 2,777 | 2,981 | 3,134 | 3,574 | 3,626 | 3,670 | 3,156 | 657 | 699 | 0 |
| Net Working Capital | 3,979 | 3,690 | 2,861 | 2,035 | 2,406 | 962 | 743 | 392 | 1,532 | 2,426 |
| Contingent Liabilities | 3,721 | 4,550 | 3,681 | 4,431 | 3,730 | 3,325 | 3,443 | 2,658 | 2,949 | 2,590 |
| Book Value per Share | 334.38 | 367.90 | 422.85 | 468.25 | 524.29 | 593.12 | 633.48 | 813.92 | 868.26 | 855.61 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 2,777 | 2,981 | 3,134 | 3,574 | 3,626 | 3,670 | 3,156 | 657 | 699 | 0 |
| Net Working Capital | 3,979 | 3,690 | 2,861 | 2,035 | 2,406 | 962 | 743 | 392 | 1,532 | 2,426 |
| Contingent Liabilities | 3,721 | 4,550 | 3,681 | 4,431 | 3,730 | 3,325 | 3,443 | 2,658 | 2,949 | 2,590 |
| Book Value per Share | 334.38 | 367.90 | 422.85 | 468.25 | 524.29 | 593.12 | 633.48 | 813.92 | 868.26 | 855.61 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2017
- Equity Capital
- 28
- 9,407
- 187
- Trade Payables
- 1,467
- 4,235
- Total Liabilities
- 15,324
- 1,596
- Capital Work in Progress
- 235
- 1,867
- 1,145
- 0
- Cash & Bank
- 252
- 10,229
- Total Assets
- 15,324
- Total Debt
- 2,777
- Net Working Capital
- 3,979
- Contingent Liabilities
- 3,721
- Book Value per Share
- 334.38
- Face Value
- 1.00
- Total Debt
- 2,777
- Net Working Capital
- 3,979
- Contingent Liabilities
- 3,721
- Book Value per Share
- 334.38
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 28
- 10,353
- 295
- Trade Payables
- 1,555
- 2,373
- Total Liabilities
- 14,604
- 1,699
- Capital Work in Progress
- 354
- 3,213
- 1,111
- 0
- Cash & Bank
- 177
- 8,050
- Total Assets
- 14,604
- Total Debt
- 2,981
- Net Working Capital
- 3,690
- Contingent Liabilities
- 4,550
- Book Value per Share
- 367.90
- Face Value
- 1.00
- Total Debt
- 2,981
- Net Working Capital
- 3,690
- Contingent Liabilities
- 4,550
- Book Value per Share
- 367.90
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 28
- 11,903
- 303
- Trade Payables
- 1,668
- 2,528
- Total Liabilities
- 16,431
- 1,413
- Capital Work in Progress
- 209
- 3,269
- 911
- 0
- Cash & Bank
- 256
- 10,371
- Total Assets
- 16,431
- Total Debt
- 3,134
- Net Working Capital
- 2,861
- Contingent Liabilities
- 3,681
- Book Value per Share
- 422.85
- Face Value
- 1.00
- Total Debt
- 3,134
- Net Working Capital
- 2,861
- Contingent Liabilities
- 3,681
- Book Value per Share
- 422.85
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 28
- 13,184
- 443
- Trade Payables
- 1,585
- 4,498
- Total Liabilities
- 19,738
- 1,612
- Capital Work in Progress
- 152
- 4,714
- 838
- 0
- Cash & Bank
- 88
- 12,334
- Total Assets
- 19,738
- Total Debt
- 3,574
- Net Working Capital
- 2,035
- Contingent Liabilities
- 4,431
- Book Value per Share
- 468.25
- Face Value
- 1.00
- Total Debt
- 3,574
- Net Working Capital
- 2,035
- Contingent Liabilities
- 4,431
- Book Value per Share
- 468.25
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 28
- 14,766
- 513
- Trade Payables
- 1,623
- 6,077
- Total Liabilities
- 23,007
- 1,722
- Capital Work in Progress
- 93
- 6,990
- 762
- 0
- Cash & Bank
- 16
- 13,423
- Total Assets
- 23,007
- Total Debt
- 3,626
- Net Working Capital
- 2,406
- Contingent Liabilities
- 3,730
- Book Value per Share
- 524.29
- Face Value
- 1.00
- Total Debt
- 3,626
- Net Working Capital
- 2,406
- Contingent Liabilities
- 3,730
- Book Value per Share
- 524.29
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 28
- 16,708
- 370
- Trade Payables
- 1,939
- 6,575
- Total Liabilities
- 25,619
- 1,752
- Capital Work in Progress
- 101
- 8,559
- 952
- 0
- Cash & Bank
- 30
- 14,225
- Total Assets
- 25,619
- Total Debt
- 3,670
- Net Working Capital
- 962
- Contingent Liabilities
- 3,325
- Book Value per Share
- 593.12
- Face Value
- 1.00
- Total Debt
- 3,670
- Net Working Capital
- 962
- Contingent Liabilities
- 3,325
- Book Value per Share
- 593.12
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 28
- 17,847
- 350
- Trade Payables
- 2,093
- 6,607
- Total Liabilities
- 26,925
- 1,746
- Capital Work in Progress
- 159
- 10,333
- 1,090
- 0
- Cash & Bank
- 94
- 13,503
- Total Assets
- 26,925
- Total Debt
- 3,156
- Net Working Capital
- 743
- Contingent Liabilities
- 3,443
- Book Value per Share
- 633.48
- Face Value
- 1.00
- Total Debt
- 3,156
- Net Working Capital
- 743
- Contingent Liabilities
- 3,443
- Book Value per Share
- 633.48
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 28
- 22,940
- 500
- Trade Payables
- 2,700
- 5,241
- Total Liabilities
- 31,410
- 1,756
- Capital Work in Progress
- 175
- 12,965
- 1,143
- 2,484
- Cash & Bank
- 129
- 12,757
- Total Assets
- 31,410
- Total Debt
- 657
- Net Working Capital
- 392
- Contingent Liabilities
- 2,658
- Book Value per Share
- 813.92
- Face Value
- 1.00
- Total Debt
- 657
- Net Working Capital
- 392
- Contingent Liabilities
- 2,658
- Book Value per Share
- 813.92
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 28
- 24,473
- 699
- Trade Payables
- 2,182
- 5,388
- Total Liabilities
- 32,770
- 1,979
- Capital Work in Progress
- 121
- 15,195
- 1,369
- 2,550
- Cash & Bank
- 133
- 11,423
- Total Assets
- 32,770
- Total Debt
- 699
- Net Working Capital
- 1,532
- Contingent Liabilities
- 2,949
- Book Value per Share
- 868.26
- Face Value
- 1.00
- Total Debt
- 699
- Net Working Capital
- 1,532
- Contingent Liabilities
- 2,949
- Book Value per Share
- 868.26
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 28
- 24,117
- 0
- Trade Payables
- 2,746
- 7,325
- Total Liabilities
- 34,216
- 2,028
- Capital Work in Progress
- 67
- 15,202
- 1,288
- 3,306
- Cash & Bank
- 293
- 12,032
- Total Assets
- 34,216
- Total Debt
- 0
- Net Working Capital
- 2,426
- Contingent Liabilities
- 2,590
- Book Value per Share
- 855.61
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 2,426
- Contingent Liabilities
- 2,590
- Book Value per Share
- 855.61
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 878 | 1,124 | 2,490 | 1,579 | 1,243 | 1,216 | 1,474 | -495 | 589 | 543 | |
| Cash from Investing | -2,580 | -1,137 | -2,256 | -1,607 | -1,235 | -897 | -431 | 3,197 | -490 | 569 |
| Cash from Financing | 1,879 | -62 | -155 | -139 | -81 | -305 | -978 | -2,666 | -95 | -952 |
| 177 | -75 | 79 | -168 | -73 | 14 | 64 | 35 | 4 | 160 | |
| Free Cash Flow | 642 | 792 | 2,490 | 1,301 | 1,049 | 1,030 | 1,259 | -721 | 293 | 325 |
| OCF / Net Profit | 0.41 | 1.11 | 1.67 | 1.17 | 0.75 | 0.61 | 1.22 | -0.10 | 0.37 | -2.71 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 6,273 | 6,662 | 7,129 | 3,918 | 2,910 | 2,185 |
| OCF / Net Profit | 0.41 | 1.11 | 1.67 | 1.17 | 0.75 | 0.61 | 1.22 | -0.10 | 0.37 | -2.71 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 6,273 | 6,662 | 7,129 | 3,918 | 2,910 | 2,185 |
Mar 2017
- 878
- Cash from Investing
- -2,580
- Cash from Financing
- 1,879
- 177
- Free Cash Flow
- 642
- OCF / Net Profit
- 0.41
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.41
- Cumulative 5-Year FCF
- 0
Mar 2018
- 1,124
- Cash from Investing
- -1,137
- Cash from Financing
- -62
- -75
- Free Cash Flow
- 792
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.11
- Cumulative 5-Year FCF
- 0
Mar 2019
- 2,490
- Cash from Investing
- -2,256
- Cash from Financing
- -155
- 79
- Free Cash Flow
- 2,490
- OCF / Net Profit
- 1.67
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.67
- Cumulative 5-Year FCF
- 0
Mar 2020
- 1,579
- Cash from Investing
- -1,607
- Cash from Financing
- -139
- -168
- Free Cash Flow
- 1,301
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.17
- Cumulative 5-Year FCF
- 0
Mar 2021
- 1,243
- Cash from Investing
- -1,235
- Cash from Financing
- -81
- -73
- Free Cash Flow
- 1,049
- OCF / Net Profit
- 0.75
- Cumulative 5-Year FCF
- 6,273
- OCF / Net Profit
- 0.75
- Cumulative 5-Year FCF
- 6,273
Mar 2022
- 1,216
- Cash from Investing
- -897
- Cash from Financing
- -305
- 14
- Free Cash Flow
- 1,030
- OCF / Net Profit
- 0.61
- Cumulative 5-Year FCF
- 6,662
- OCF / Net Profit
- 0.61
- Cumulative 5-Year FCF
- 6,662
Mar 2023
- 1,474
- Cash from Investing
- -431
- Cash from Financing
- -978
- 64
- Free Cash Flow
- 1,259
- OCF / Net Profit
- 1.22
- Cumulative 5-Year FCF
- 7,129
- OCF / Net Profit
- 1.22
- Cumulative 5-Year FCF
- 7,129
Mar 2024
- -495
- Cash from Investing
- 3,197
- Cash from Financing
- -2,666
- 35
- Free Cash Flow
- -721
- OCF / Net Profit
- -0.10
- Cumulative 5-Year FCF
- 3,918
- OCF / Net Profit
- -0.10
- Cumulative 5-Year FCF
- 3,918
Mar 2025
- 589
- Cash from Investing
- -490
- Cash from Financing
- -95
- 4
- Free Cash Flow
- 293
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- 2,910
- OCF / Net Profit
- 0.37
- Cumulative 5-Year FCF
- 2,910
Mar 2026
- 543
- Cash from Investing
- 569
- Cash from Financing
- -952
- 160
- Free Cash Flow
- 325
- OCF / Net Profit
- -2.71
- Cumulative 5-Year FCF
- 2,185
- OCF / Net Profit
- -2.71
- Cumulative 5-Year FCF
- 2,185
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 75.86 | 35.95 | 52.74 | 48.00 | 58.46 | 70.80 | 42.84 | 183.11 | 57.07 | -7.12 |
| Book Value (₹) | 334.38 | 367.90 | 422.85 | 468.25 | 524.29 | 593.12 | 633.48 | 813.92 | 868.26 | 855.61 |
| Dividend per Share (₹) | 2.00 | 2.00 | 2.00 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Cash EPS (₹) | 79.58 | 39.35 | 56.51 | 52.91 | 63.80 | 76.46 | 49.36 | 190.28 | 64.81 | 1.24 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 37.64% | 23.41% | 25.92% | 25.54% | 27.45% | 25.60% | 26.78% | 13.22% | 22.78% | 11.57% |
| Net Margin % | 26.44% | 15.77% | 21.40% | 18.10% | 19.80% | 22.21% | 13.16% | 55.01% | 16.34% | -2.16% |
| ROE % | 25.48% | 10.24% | 13.34% | 10.77% | 11.78% | 12.67% | 6.98% | 25.30% | 6.78% | -0.83% |
| ROCE % | 26.57% | 11.02% | 14.36% | 11.24% | 12.54% | 13.25% | 8.58% | 32.59% | 9.02% | -0.76% |
| 16.27% | 6.78% | 9.59% | 7.49% | 7.72% | 8.22% | 4.60% | 17.72% | 5.02% | -0.60% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 156 | 219 | 155 | 96 | 95 | 105 | 103 | 97 | 93 | 115 |
| Inventory Days | 48 | 64 | 53 | 43 | 35 | 35 | 41 | 43 | 47 | 52 |
| Payable Days | 239 | 272 | 254 | 227 | 198 | 191 | 221 | 278 | 284 | 298 |
| -35 | 11 | -46 | -88 | -69 | -51 | -78 | -138 | -145 | -131 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.29x | 0.29x | 0.26x | 0.27x | 0.25x | 0.22x | 0.18x | 0.03x | 0.03x | 0.00x |
| Interest Coverage (x) | 17.73x | 7.38x | 9.12x | 6.99x | 8.31x | 10.90x | 8.60x | 26.26x | 45.20x | -2.38x |
| 2.37x | 2.69x | 2.25x | 1.68x | 1.61x | 1.20x | 1.19x | 1.08x | 1.47x | 1.66x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 30.51% | -20.54% | -1.98% | 6.47% | 12.74% | 7.58% | 0.97% | -4.01% | 16.92% | -8.52% |
| Operating Profit Growth % | 61.85% | -50.58% | 19.76% | 5.99% | 19.65% | 0.71% | 6.77% | -1.99% | 7.92% | -28.88% |
| Net Profit Growth % | 44.22% | -52.61% | 46.73% | -8.99% | 21.77% | 21.12% | -39.49% | 327.48% | -68.84% | -112.47% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 327.45% | -68.84% | -112.47% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.23x | 26.99x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.18x | 1.77x | 2.49x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.26% | 0.16% | 0.12% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 11.43x | 16.93x | 32.39x |
Mar 2017
- EPS (₹)
- 75.86
- Book Value (₹)
- 334.38
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 79.58
- Operating Margin %
- 37.64%
- Net Margin %
- 26.44%
- ROE %
- 25.48%
- ROCE %
- 26.57%
- 16.27%
- Debtor Days
- 156
- Inventory Days
- 48
- Payable Days
- 239
- -35
- Debt to Equity (x)
- 0.29x
- Interest Coverage (x)
- 17.73x
- 2.37x
- Revenue Growth %
- 30.51%
- Operating Profit Growth %
- 61.85%
- Net Profit Growth %
- 44.22%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 35.95
- Book Value (₹)
- 367.90
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 39.35
- Operating Margin %
- 23.41%
- Net Margin %
- 15.77%
- ROE %
- 10.24%
- ROCE %
- 11.02%
- 6.78%
- Debtor Days
- 219
- Inventory Days
- 64
- Payable Days
- 272
- 11
- Debt to Equity (x)
- 0.29x
- Interest Coverage (x)
- 7.38x
- 2.69x
- Revenue Growth %
- -20.54%
- Operating Profit Growth %
- -50.58%
- Net Profit Growth %
- -52.61%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 52.74
- Book Value (₹)
- 422.85
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 56.51
- Operating Margin %
- 25.92%
- Net Margin %
- 21.40%
- ROE %
- 13.34%
- ROCE %
- 14.36%
- 9.59%
- Debtor Days
- 155
- Inventory Days
- 53
- Payable Days
- 254
- -46
- Debt to Equity (x)
- 0.26x
- Interest Coverage (x)
- 9.12x
- 2.25x
- Revenue Growth %
- -1.98%
- Operating Profit Growth %
- 19.76%
- Net Profit Growth %
- 46.73%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 48.00
- Book Value (₹)
- 468.25
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 52.91
- Operating Margin %
- 25.54%
- Net Margin %
- 18.10%
- ROE %
- 10.77%
- ROCE %
- 11.24%
- 7.49%
- Debtor Days
- 96
- Inventory Days
- 43
- Payable Days
- 227
- -88
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 6.99x
- 1.68x
- Revenue Growth %
- 6.47%
- Operating Profit Growth %
- 5.99%
- Net Profit Growth %
- -8.99%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 58.46
- Book Value (₹)
- 524.29
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 63.80
- Operating Margin %
- 27.45%
- Net Margin %
- 19.80%
- ROE %
- 11.78%
- ROCE %
- 12.54%
- 7.72%
- Debtor Days
- 95
- Inventory Days
- 35
- Payable Days
- 198
- -69
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 8.31x
- 1.61x
- Revenue Growth %
- 12.74%
- Operating Profit Growth %
- 19.65%
- Net Profit Growth %
- 21.77%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 70.80
- Book Value (₹)
- 593.12
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 76.46
- Operating Margin %
- 25.60%
- Net Margin %
- 22.21%
- ROE %
- 12.67%
- ROCE %
- 13.25%
- 8.22%
- Debtor Days
- 105
- Inventory Days
- 35
- Payable Days
- 191
- -51
- Debt to Equity (x)
- 0.22x
- Interest Coverage (x)
- 10.90x
- 1.20x
- Revenue Growth %
- 7.58%
- Operating Profit Growth %
- 0.71%
- Net Profit Growth %
- 21.12%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 42.84
- Book Value (₹)
- 633.48
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 49.36
- Operating Margin %
- 26.78%
- Net Margin %
- 13.16%
- ROE %
- 6.98%
- ROCE %
- 8.58%
- 4.60%
- Debtor Days
- 103
- Inventory Days
- 41
- Payable Days
- 221
- -78
- Debt to Equity (x)
- 0.18x
- Interest Coverage (x)
- 8.60x
- 1.19x
- Revenue Growth %
- 0.97%
- Operating Profit Growth %
- 6.77%
- Net Profit Growth %
- -39.49%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 183.11
- Book Value (₹)
- 813.92
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 190.28
- Operating Margin %
- 13.22%
- Net Margin %
- 55.01%
- ROE %
- 25.30%
- ROCE %
- 32.59%
- 17.72%
- Debtor Days
- 97
- Inventory Days
- 43
- Payable Days
- 278
- -138
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 26.26x
- 1.08x
- Revenue Growth %
- -4.01%
- Operating Profit Growth %
- -1.99%
- Net Profit Growth %
- 327.48%
- 327.45%
- P/E (x)
- 5.23x
- P/B (x)
- 1.18x
- Dividend Yield %
- 0.26%
- 11.43x
Mar 2025
- EPS (₹)
- 57.07
- Book Value (₹)
- 868.26
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 64.81
- Operating Margin %
- 22.78%
- Net Margin %
- 16.34%
- ROE %
- 6.78%
- ROCE %
- 9.02%
- 5.02%
- Debtor Days
- 93
- Inventory Days
- 47
- Payable Days
- 284
- -145
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 45.20x
- 1.47x
- Revenue Growth %
- 16.92%
- Operating Profit Growth %
- 7.92%
- Net Profit Growth %
- -68.84%
- -68.84%
- P/E (x)
- 26.99x
- P/B (x)
- 1.77x
- Dividend Yield %
- 0.16%
- 16.93x
Mar 2026
- EPS (₹)
- -7.12
- Book Value (₹)
- 855.61
- Dividend per Share (₹)
- 2.50
- Cash EPS (₹)
- 1.24
- Operating Margin %
- 11.57%
- Net Margin %
- -2.16%
- ROE %
- -0.83%
- ROCE %
- -0.76%
- -0.60%
- Debtor Days
- 115
- Inventory Days
- 52
- Payable Days
- 298
- -131
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- -2.38x
- 1.66x
- Revenue Growth %
- -8.52%
- Operating Profit Growth %
- -28.88%
- Net Profit Growth %
- -112.47%
- -112.47%
- P/E (x)
- 0.00x
- P/B (x)
- 2.49x
- Dividend Yield %
- 0.12%
- 32.39x
Documents
Announcements
- Press Release
2026-08-21 - Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10,000 mg/100 mL (100 mg/mL) Pharmacy Bulk Package".
- Press Release
2026-08-20 - Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray".
Annual Reports
Nothing filed yet.
Credit Ratings
- Credit Rating
2025-09-19 - Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating
- Credit Rating- Revision
2025-07-23 - Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating- Revision
Concalls
Aug 2026
Jun 2026
May 2026